BUBBFOREST · QUALITY · SCIENCE · REAL-WORLD CONTEXT
Quality & Manufacturing
Know where a product comes from, which manufacturing documents support it, and what its batch records actually show.
Updated 15 September 2026AUSTRALIAN MANUFACTURING
Costar Pharma: documented GMP manufacturing
Costar Pharma Laboratory Pty Ltd is the Australian manufacturer identified in our D3 gummy manufacturing documentation. Its TGA Certificate of GMP Compliance identifies the manufacturing site at 171–177 Woodpark Road, Smithfield, NSW, Australia.
- GMP certificate: MI-2025-LI-07688-1.
- Manufacturing licence: MI-2014-LI-01856-1.
- Issued: 13 March 2026. Stated expiry: 11 April 2029, subject to the conditions and scheduled re-inspections in the certificate.
The scope includes pastilles and several other non-sterile dosage forms. Manufacture, testing and storage have defined scopes; the additional conditions restrict the stated chemical/physical testing step to physical testing only. This document describes the named facility, not a brand-wide product approval.
PRODUCT & BATCH
D3 gummies: from manufacture to batch testing
The manufacturing record names Super Clinical D3 Gummy (Ampli-D Gummy), 60s, product code 724 / Z724Z60, bulk batch CS25707 and finished-product batch 25711. Manufacture: March 2026; expiry: March 2028. Costar issued the conformity declaration on 4 April 2026.
ScienTEST Analytical Services report 26030866, dated 2 April 2026, identifies the same sample and batch. Reported results include arsenic, cadmium and lead each below 0.1 ppm, mercury below 0.01 ppm, aerobic microbial count below 100 CFU/g, and yeast and mould below 100 CFU/g. E. coli, Salmonella and S. aureus were absent in the stated test quantities.
These are results for the identified batch and test panel, not an assay of calcifediol potency or a clinical efficacy trial. The archive also contains shipment-specific Australian origin and export documentation for this product.
Australian product listing
AUST L 527866 identifies BubbForest calcifediol D3 in the ARTG. Match the AUST L number and current packaging to the product you buy. Ingredient-level ampli-D® research is explained separately in our Clinical Evidence Library.
NEW ZEALAND · 120 CAPSULES
Inositol: traceable New Zealand batches
Unipharm Healthy Manufacturing Co. Limited, Auckland, is identified in the records for BUBBFOREST MYO&D-CHIRO INOSITOL 120 Capsules, product code UF2206. The two certificates of analysis record physical appearance, capsule gross weight and microbiological testing, with release by Unipharm QA.
| Batch | Manufactured | Expiry | COA / report |
|---|---|---|---|
| U601404 | 2026-01-22 | 2029-01-21 | 2026-02-04 · 26-22256 |
| U602155 | 2026-01-30 | 2029-01-29 | 2026-02-11 · 26-32370 |
Both COAs report conformity for the stated tests. Aerobic plate counts were 100 and 380 CFU/g respectively (specification ≤10,000 CFU/g); yeast and mould were below 10 CFU/g (specification ≤100 CFU/g). The named pathogens were not detected in the stated test quantities. The certificates do not quantify every active ingredient.
New Zealand origin certificate TW2026.12347, dated 4 March 2026, and Ministry for Primary Industries free sale certificate NZL2026/UNIPHARM1/54, dated 5 March 2026, identify these batches. The records apply to this 120-capsule version and these shipments, not automatically to a 90-capsule or other market formulation.
DEFINED SCOPE
TGA, FDA and NSF: different roles in quality
TGA: manufacturer GMP and product-specific ARTG records
The Costar GMP certificate concerns its manufacturing site. ARTG entries concern named Australian products: D3 (527866), Ultra Deep Marine Omega3 (529015) and ATP FLUX (529815). AUST L listing does not mean pre-market evaluation of efficacy and is not approval for every country.
FDA: food-facility registration
Unipharm’s supplied 2026 registration documentation is issued by Registrar Corp and identifies the New Zealand manufacturing facility. Food-facility registration is an administrative registration, not FDA approval of BubbForest or its products. FDA does not issue or recognize private registration certificates as FDA certificates. Registration identifiers and private shipment details are not displayed here.
NSF GMP: manufacturing-facility standards
The supplied NSF GMP document names Makers Nutrition, LLC. Its public credentials page now provides 2026 manufacturing documentation. NSF GMP applies to the named facility and certified scope; it is distinct from certification of a finished supplement. We do not use a factory document as an NSF Certified for Sport claim for BubbForest products. The historical certificate expiring 7 March 2024 is retained in the archive rather than shown as current.